Symbol="PIRS"
AssetType="Common Stock"
Name="Pieris Pharmaceuticals Inc"
Description="Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anti-calcium protein-based drugs in the United States. The company is headquartered in Boston, Massachusetts."
CIK="1583648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="255 STATE STREET, 9TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="18118000"
EBITDA="-48998000"
PERatio="None"
PEGRatio="0"
BookValue="0.207"
DividendPerShare="0"
DividendYield="0"
EPS="-0.55"
RevenuePerShareTTM="0.227"
ProfitMargin="-2.454"
OperatingMarginTTM="-3.058"
ReturnOnAssetsTTM="-0.294"
ReturnOnEquityTTM="-1.2"
RevenueTTM="16850000"
GrossProfitTTM="-27080000"
DilutedEPSTTM="-0.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.824"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.596"
PriceToBookRatio="2.08"
EVToRevenue="0.589"
EVToEBITDA="-0.49"
Beta="0.835"
num_52WeekHigh="1.97"
num_52WeekLow="0.162"
num_50DayMovingAverage="0.431"
num_200DayMovingAverage="0.961"
SharesOutstanding="82019000"
DividendDate="None"
ExDividendDate="None"
symbol="PIRS"
open="0.23"
high="0.23"
low="0.22"
price="0.22"
volume="580724.00"
latest_trading_day="2023-08-08"
previous_close="0.22"
change="-0.00"
change_percent="-0.3166%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="1922098"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.71"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="1087"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0120.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="652"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0056.jpeg"
image_positive_thumbnail_id_2="676"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
